Alterations of the HBP1 Transcriptional Repressor Are Associated with Invasive Breast Cancer
Authors:
- 1 July 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (13) , 6136-6145
Abstract
Invasive breast cancer has a high risk of recurrence to incurable disease and needs improved prognostic and therapeutic tools. Our work combines clinical and molecular analyses to show that the transcriptional repressor HBP1 may be a new target for invasive breast cancer. Previous work indicated that HBP1 regulated proliferation and senescence and inhibited Wnt signaling. Two of these functions have been associated with invasive breast cancer. In 76 breast tumors, we identified 10 HBP1 mutations/variants that were associated with fully invasive breast cancer. In a separate analysis, we found that a subset of invasive breast cancer specimens also had reduced HBP1 mRNA levels. These clinical correlations suggested that mutation or reduction of HBP1 occurs in invasive breast cancer and that HBP1 might regulate the proliferation and invasiveness of this breast cancer type. Analysis of the HBP1 mutants showed they were functionally defective for suppressing Wnt signaling. To test the consequences of reduced HBP1 levels, we used RNA interference to knock down HBP1 and observed increased Wnt signaling, tumorigenic proliferation, and invasiveness in cell and animal breast cancer models. Lastly, statistical analysis of a breast cancer patient database linked reduced HBP1 expression to breast cancer recurrence. In considering two-gene criteria for relapse potential, reduced expression of HBP1 and SFRP1, which is another Wnt inhibitor that was recently linked to invasive breast cancer, strikingly correlated with recurrence. Together, these data indicate that HBP1 may be a molecularly and clinically relevant regulator of breast cancer transitions that eventually lead to poor prognosis. [Cancer Res 2007;67(13):6136–45]Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- The HBP1 Transcriptional Repressor Participates in RAS-Induced Premature SenescenceMolecular and Cellular Biology, 2006
- Suppression of Wnt Signaling by the Green Tea Compound (–)-Epigallocatechin 3-Gallate (EGCG) in Invasive Breast Cancer CellsJournal of Biological Chemistry, 2006
- Wnt signalling in stem cells and cancerNature, 2005
- HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientationsNature Structural & Molecular Biology, 2004
- The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppressionGene, 2004
- The Transcriptional Repressor HBP1 Is a Target of the p38 Mitogen-Activated Protein Kinase Pathway in Cell Cycle RegulationMolecular and Cellular Biology, 2003
- Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2Genes, Chromosomes and Cancer, 2003
- HMG Box Transcriptional Repressor HBP1 Maintains a Proliferation Barrier in Differentiated Liver TissueMolecular and Cellular Biology, 2001
- RNase cleavage-based methods for mutation/SNP detection, past and presentHuman Mutation, 2001
- HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family.Genes & Development, 1997